These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26553163)

  • 1. Rabbit Models of Ocular Diseases: New Relevance for Classical Approaches.
    Zernii EY; Baksheeva VE; Iomdina EN; Averina OA; Permyakov SE; Philippov PP; Zamyatnin AA; Senin II
    CNS Neurol Disord Drug Targets; 2016; 15(3):267-91. PubMed ID: 26553163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zebrafish--on the move towards ophthalmological research.
    Chhetri J; Jacobson G; Gueven N
    Eye (Lond); 2014 Apr; 28(4):367-80. PubMed ID: 24503724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Microarrays: Valuable Tools for Ocular Diseases Research.
    Garranzo-Asensio M; Montero-Calle A; Solís-Fernández G; Barderas R; Guzman-Aranguez A
    Curr Med Chem; 2020; 27(27):4549-4566. PubMed ID: 31244416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Relevant Models for Ocular Inflammatory Diseases.
    Gilger BC
    ILAR J; 2018 Dec; 59(3):352-362. PubMed ID: 29474707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Patents and Emerging Therapeutics on Ocular Inflammation and Allergy.
    Agrahari V; Aulgur Z; Thukral S; Dhall N; Conley R; Mitra AK
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(2):92-106. PubMed ID: 28901856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Principles of Ocular Pharmacology.
    Park Y; Ellis D; Mueller B; Stankowska D; Yorio T
    Handb Exp Pharmacol; 2017; 242():3-30. PubMed ID: 27730396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-environment interactions in ocular diseases.
    Sacca SC; Bolognesi C; Battistella A; Bagnis A; Izzotti A
    Mutat Res; 2009 Jul; 667(1-2):98-117. PubMed ID: 19046976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery strategies for treatment of age-related ocular diseases: From a biological understanding to biomaterial solutions.
    Delplace V; Payne S; Shoichet M
    J Control Release; 2015 Dec; 219():652-668. PubMed ID: 26435454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development.
    Shah M; Cabrera-Ghayouri S; Christie LA; Held KS; Viswanath V
    Pharm Res; 2019 Feb; 36(4):58. PubMed ID: 30805711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oculoscopy in Rabbits and Rodents.
    Jekl V; Hauptman K; Knotek Z
    Vet Clin North Am Exot Anim Pract; 2015 Sep; 18(3):417-29. PubMed ID: 26117523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals.
    Neroev VV; Archipova MM; Bakeeva LE; Fursova AZh; Grigorian EN; Grishanova AY; Iomdina EN; Ivashchenko ZhN; Katargina LA; Khoroshilova-Maslova IP; Kilina OV; Kolosova NG; Kopenkin EP; Korshunov SS; Kovaleva NA; Novikova YP; Philippov PP; Pilipenko DI; Robustova OV; Saprunova VB; Senin II; Skulachev MV; Sotnikova LF; Stefanova NA; Tikhomirova NK; Tsapenko IV; Shchipanova AI; Zinovkin RA; Skulachev VP
    Biochemistry (Mosc); 2008 Dec; 73(12):1317-28. PubMed ID: 19120017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular pharmacology.
    Novack GD; Robin AL
    J Clin Pharmacol; 2016 May; 56(5):517-27. PubMed ID: 26360129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New ocular therapeutics: a view from the patenting perspective.
    Mucke HA
    IDrugs; 2007 Jan; 10(1):37-41. PubMed ID: 17187313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and eye diseases.
    Poh S; Mohamed Abdul RB; Lamoureux EL; Wong TY; Sabanayagam C
    Diabetes Res Clin Pract; 2016 Mar; 113():86-100. PubMed ID: 26838669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microengineered biomimetic ocular models for ophthalmological drug development.
    Estlack Z; Bennet D; Reid T; Kim J
    Lab Chip; 2017 May; 17(9):1539-1551. PubMed ID: 28401229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fundamental ophthalmology: the role of electrophysiological studies].
    Zueva MV
    Vestn Oftalmol; 2014; 130(6):28-36. PubMed ID: 25715550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive review on contact lens for ophthalmic drug delivery.
    Xu J; Xue Y; Hu G; Lin T; Gou J; Yin T; He H; Zhang Y; Tang X
    J Control Release; 2018 Jul; 281():97-118. PubMed ID: 29782944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphological basics of scientific research in ophthalmology].
    Fedorov AA
    Vestn Oftalmol; 2013; 129(5):10-21. PubMed ID: 24261276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular disease and driving.
    Wood JM; Black AA
    Clin Exp Optom; 2016 Sep; 99(5):395-401. PubMed ID: 27156178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.